Atlas Trials

Macular Edema Incidence/Severity Reduction With Nevanac

Clinical trial NCT00939276 · TERMINATED

Trial details

NCT number
NCT00939276
Sponsor
Alcon Research
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Retinopathy
Start date
2009-08-01
Primary completion
2011-05-01
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.